Natural IgM antibodies reduce the prothrombotic potential of post-translationally modified collagen

12 April 2024 (08:30 - 14:00)

Organised by:

Sign in for access options

About the speaker

Doctor Thomas Koller

Medical University of Vienna, Vienna (Austria)

4 More presentations in this session

Presentation thumbnail

A novel cardiovascular-kidney-metabolic syndrome mouse model with inducible HFrEF and atherosclerosis

Doctor A. Van Koppen (Den Haag, NL)

Presentation thumbnail

Chronic myocardial infarction heterogeneously alters the response to isoprenaline in the porcine left ventricle

Miss A. Perez-Martinez (Zaragoza, ES)

Presentation thumbnail

High-throughput approach to identify release mechanisms of proinflammatory extracellular vesicles

Ms L. Zisser (AT)

Presentation thumbnail

Biomarkers reflecting myocardial, metabolic, and vascular disease processes identify patients with atrial fibrillation at high risk of cardiovascular events: EAST-AFNET 4 biomolecule study.

Professor L. Fabritz (Hamburg, DE)

Access the full session

Session thumbnail

Late-breaking science

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2024

12 April - 14 April 2024

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources